Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 3, 2020Translational OncologyOpen Access

Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models

View Full Paper
Ask AI
Bookmark
Share

Authors

TRTristan RuppOPOcéane PelouinLGLaurie Genest

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rupp et al. (2020) studied this question.

synapsesocial.com/papers/6a24a075ef83ecbb390c0bdfhttps://doi.org/10.1016/j.tranon.2020.100926
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 13D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained2016 · 1,144 citations
  2. 2Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes2019 · 83 citations
  3. 3Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer2015 · 100 citations